Advertisement

Topics

No evidence higher doses of cholesterol-lowering drug increase risk of acute kidney damage

03:00 EDT 31 Jul 2017 | Medical Xpress

New Zealanders taking a higher dose of simvastatin, one of the cholesterol-lowering statin drugs used to prevent heart attacks and strokes, do not appear to have a higher risk of acute kidney damage than those taking a lower dose, according to University of Otago researchers from the Pharmacoepidemiology Research Network.

Original Article: No evidence higher doses of cholesterol-lowering drug increase risk of acute kidney damage

NEXT ARTICLE

More From BioPortfolio on "No evidence higher doses of cholesterol-lowering drug increase risk of acute kidney damage"

Quick Search
Advertisement
 

Relevant Topics

Statins
Statins (or HMG-CoA reductase inhibitors) are a class of drug used to lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver. Increased cholesterol levels have been as...

Cholesterol
Cholesterol is a waxy steroid metabolite found in the cell membranes and transported in the blood plasma. It is an important structural component of mammalian cell membranes, where it is establishes proper membrane permeability and fluidity. Cholesterol ...